Healthy volunteers help test safety of experimental drug NEU-627
NCT ID NCT06900751
First seen Jan 19, 2026 · Last updated May 08, 2026 · Updated 16 times
Summary
This early-stage study tested a new drug, NEU-627, in 74 healthy adults to see if it is safe and how the body handles it. Participants received either the drug or a placebo, and researchers monitored side effects and drug levels in the blood. This study does not aim to treat any disease, but the information gathered will guide future research.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
New Zealand Clinical Research
Grafton, Aukland, 1010, New Zealand
Conditions
Explore the condition pages connected to this study.